BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5
656 results:

  • 1. Declining incidence and improving survival of ocular and orbital lymphomas in the US between 1995 and 2018.
    Alfaar AS; Yousef YA; W Wilson M; Hassanain O; Kakkassery V; Moustafa M; Kunbaz A; Esmael A; Strauß O
    Sci Rep; 2024 Apr; 14(1):7886. PubMed ID: 38570585
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Proximal Humerus Reconstruction for bone Sarcomas: A Critical Analysis.
    Houdek MT; Sullivan MH; Broida SE; Barlow JD; Morrey ME; Moran SL; Sanchez-Sotelo J
    JBJS Rev; 2024 Mar; 12(3):. PubMed ID: 38466801
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Screening for Synergistic Reagents With Pazopanib Against Osteosarcoma Using a Compound Library.
    Yada Y; Asanuma K; Kakimto T; Okuno K; Okamoto T; Iino T; Nakamura T; Sudo A
    Anticancer Res; 2024 Mar; 44(3):1071-1078. PubMed ID: 38423639
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Similar complications, implant survival, and function following modular prosthesis and allograft-prosthesis composite reconstructions of the proximal femur for primary bone tumors: a systematic review and meta-analysis.
    Atherley O'Meally A; Cosentino M; Aiba H; Aso A; Solou K; Rizzi G; Bordini B; Donati DM; Errani C
    Eur J Orthop Surg Traumatol; 2024 Apr; 34(3):1581-1595. PubMed ID: 38363346
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Copy Number Gain in Androgen Receptors Predicts the Poor Prognosis in Japanese Castration-resistant Prostate cancer.
    Sakamoto S; Ando K; Pae S; Zhao X; Sakai K; Sato K; Saito S; Yamada Y; Rii J; Goto Y; Sazuka T; Imamura Y; Anzai N; Akakura K; Nishio K; Ichikawa T
    Anticancer Res; 2024 Feb; 44(2):639-647. PubMed ID: 38307556
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pachydysostosis of the fibula in a case of familial adenomatous polyposis.
    Oliveira D; Maia S; Balacó I; Coelho P; Almeida S; Venâncio M; Saraiva J; Nishimura G; Sousa SB
    Eur J Med Genet; 2024 Apr; 68():104913. PubMed ID: 38286305
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
    Tsukamoto S; Mavrogenis AF; Nitta Y; Righi A; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Tanaka Y; Errani C
    Curr Oncol; 2024 Jan; 31(1):566-578. PubMed ID: 38275833
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Comparative study of orthopaedic robot-assisted minimally invasive surgery and open surgery for limb osteoid osteoma].
    Feng J; Liang W; Wang Y; Tang Z; A M; Xu B; He N; Hao P
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2024 Jan; 38(1):40-45. PubMed ID: 38225839
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study.
    Sathekge MM; Lawal IO; Bal C; Bruchertseifer F; Ballal S; Cardaci G; Davis C; Eiber M; Hekimsoy T; Knoesen O; Kratochwil C; Lenzo NP; Mahapane J; Maserumule LC; Mdlophane AH; Mokoala KMG; Ndlovu H; Pant V; Rathke H; Reed J; Sen IB; Singh A; Sood A; Tauber R; Thakral P; Yadav MP; Morgenstern A
    Lancet Oncol; 2024 Feb; 25(2):175-183. PubMed ID: 38218192
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Reconstruction following oncological iliosacral resection.
    Broida SE; Tsoi KM; Rose PS; Ferguson PC; Griffin AM; Wunder JS; Houdek MT
    Bone Joint J; 2024 Jan; 106-B(1):93-98. PubMed ID: 38160693
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Unraveling the Natural History of Good's Syndrome: A Progressive Adult Combined Immunodeficiency.
    Kabir A; Polito V; Tsoukas CM
    J Allergy Clin Immunol Pract; 2024 Mar; 12(3):744-752.e3. PubMed ID: 38122866
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases.
    Kanankulam Velliangiri S; Ballal S; Prasad Yadhav M; Tripathi M; Satapathy S; Bal C
    PLoS One; 2023; 18(11):e0294343. PubMed ID: 37963164
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [The expression of neuraminidase-1 in Ewing sarcoma and its impact on sarcoma cell proliferation and migration].
    Liu BF; Gao YZ
    Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(41):3287-3293. PubMed ID: 37926573
    [No Abstract]    [Full Text] [Related]  

  • 14. Incidence and Bayesian Mapping of Myeloid Hematologic Malignancies in Sardinia, Italy.
    Broccia G; Carter J; Ozsin-Ozler C; De Matteis S; Cocco P
    Cancer Control; 2023; 30():10732748231202906. PubMed ID: 37877513
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment.
    Yang M; Su Y; Xu K; Zheng H; Yuan Q; Cai Y; Aihaiti Y; Xu P
    J Orthop Surg Res; 2023 Oct; 18(1):787. PubMed ID: 37858131
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Long-term effectiveness of uncemented allograft-prosthesis composite for reconstruction of bone defects after proximal femur tumor resection].
    Wang Y; Lu M; Zhang Y; He X; Li Z; Gong T; Wang Y; Zhou Y; Luo Y; Tang F; Zhang W; Duan H; Tu C; Min L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2023 Oct; 37(10):1190-1197. PubMed ID: 37848312
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Transurethral plasma resection of the prostate for acute urinary retention in patients with advanced prostate cancer].
    Pang K; Liang Q; Chen B; Shi ZD; Dong Y; Han CH
    Zhonghua Nan Ke Xue; 2023 Jan; 29(1):25-30. PubMed ID: 37846828
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical efficacy analysis of percutaneous "tripod" combined with radiofrequency ablation and bone cement filling in the treatment of periacetabular metastases.
    Lan Y; Li R; Jiang L; Zhou N; He M; Fang B; Yi C
    J Orthop Surg Res; 2023 Oct; 18(1):767. PubMed ID: 37817253
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Diagnostic Performance of PSMA-Based 18 F-DCFPyL PET/CT in Prostate cancer Patients After Definitive Treatment With PSA Level ≤0.2 ng/mL.
    Lu Y; Wilson ZJ; Xu G; Xu Z; Pan T; Wei P
    Clin Nucl Med; 2023 Dec; 48(12):1021-1027. PubMed ID: 37801580
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate cancer: A Real-World, Multicenter, Retrospective Analysis.
    Pisano C; Turco F; Arnaudo E; Fea E; Vanella P; Ruatta F; Filippi R; Brusa F; Prati V; Vana F; Mennitto A; Cattrini C; Vignani F; Dionisio R; Icardi M; Guglielmini P; Buosi R; Stevani I; Vormola R; Numico G; Depetris I; Comandone A; Gennari A; Airoldi M; Rossi M; Vellani G; Ortega C; Tucci M; Maio MD; Buttigliero C
    Clin Genitourin Cancer; 2024 Apr; 22(2):56-67.e16. PubMed ID: 37798164
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 33.